Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par promoteur : Wyeth Research Division of Wyeth Pharmaceutical Inc., Clinical Research and Development

Femme et Homme Max 99 ans
Wyeth Research Division of Wyeth Pharmaceutical Inc., Clinical Research and Development MAJ Il y a 4 ans

A 24-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF PPM-204 IN SUBJECTS WITH TYPE 2 DIABETES To identify doses of PPM-204 that are therapeutically effective and well tolerated in improving glycemic control in subjects with type 2 diabetes mellitus (T2DM).

Pays Aucun
Organes Aucun
Spécialités Aucune

Essai clos aux inclusions

Plus d'informations